Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842374 · ClinicalTrials.gov registry record
Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
A clinical trial of Non-STEMI Acute Coronary Syndrome, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- 32
- Enrollment target
- 1
- Study location
NCT00842374 is a study of Non-STEMI Acute Coronary Syndrome that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00842374, a study of Non-STEMI Acute Coronary Syndrome, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a registry of patients with non ST segment elevation Myocardial Infarction (heart attack) and/or unstable acute coronary artery syndrome treated with a standardized protocol including Bivalirudin. Data will be collected on diagnosis, treatment and outcomes.
Conditions Studied
Study Locations (1)
Minnesota
- Ridgeview Medical Center - Waconia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842374
The ClinicalTrials.gov registry entry for NCT00842374 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-STEMI Acute Coronary Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00842374 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00842374 about?
NCT00842374 is a clinical study titled "Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin". This is a registry of patients with non ST segment elevation Myocardial Infarction (heart attack) and/or unstable acute coronary artery syndrome treated with a standardized protocol including Bivalirudin. Data will be collected on diagnosis, treatment and outcomes.
What is the current status of trial NCT00842374?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2008-12. Estimated completion is 2012-12.
What conditions does trial NCT00842374 study?
This clinical trial studies the following conditions: Non-STEMI Acute Coronary Syndrome.
Who is sponsoring clinical trial NCT00842374?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00842374 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.